Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ)
CNY 6.79
(1.19%)
CNY 6.79
(1.19%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 247.69 Million CNY | 16.71% |
| 2022 | 212.22 Million CNY | 32.06% |
| 2021 | 160.7 Million CNY | 475.48% |
| 2020 | 27.92 Million CNY | 105.33% |
| 2019 | -524.34 Million CNY | -328.31% |
| 2018 | 229.66 Million CNY | 31.0% |
| 2017 | 175.31 Million CNY | 6.24% |
| 2016 | 165.02 Million CNY | 111.36% |
| 2015 | 78.08 Million CNY | 97.83% |
| 2014 | 39.46 Million CNY | 10.87% |
| 2013 | 35.59 Million CNY | -27.68% |
| 2012 | 49.22 Million CNY | 2.33% |
| 2011 | 48.1 Million CNY | 12.81% |
| 2010 | 42.63 Million CNY | 30.0% |
| 2009 | 32.79 Million CNY | 25.37% |
| 2008 | 26.16 Million CNY | 2.23% |
| 2007 | 25.59 Million CNY | 116.86% |
| 2006 | 11.8 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 28.79 Million CNY | -55.25% |
| 2024 Q1 | 71.08 Million CNY | 35.78% |
| 2024 Q2 | 64.35 Million CNY | -9.46% |
| 2023 Q3 | 40.74 Million CNY | -39.13% |
| 2023 Q1 | 87.67 Million CNY | 282.54% |
| 2023 Q4 | 52.34 Million CNY | 28.49% |
| 2023 FY | 247.69 Million CNY | 16.71% |
| 2023 Q2 | 66.93 Million CNY | -23.65% |
| 2022 Q3 | 38.79 Million CNY | -38.64% |
| 2022 FY | 212.22 Million CNY | 32.06% |
| 2022 Q4 | 22.91 Million CNY | -40.92% |
| 2022 Q2 | 63.22 Million CNY | -5.43% |
| 2022 Q1 | 66.85 Million CNY | 106.98% |
| 2021 Q3 | 22.62 Million CNY | -53.92% |
| 2021 Q1 | 56.67 Million CNY | 506.61% |
| 2021 Q2 | 49.09 Million CNY | -13.37% |
| 2021 Q4 | 32.3 Million CNY | 42.77% |
| 2021 FY | 160.7 Million CNY | 475.48% |
| 2020 Q3 | -2.06 Million CNY | -104.15% |
| 2020 Q2 | 49.76 Million CNY | -7.74% |
| 2020 Q1 | 53.94 Million CNY | 129.85% |
| 2020 FY | 27.92 Million CNY | 105.33% |
| 2020 Q4 | 9.34 Million CNY | 552.74% |
| 2019 Q1 | 67.61 Million CNY | 17.62% |
| 2019 FY | -524.34 Million CNY | -328.31% |
| 2019 Q3 | -341.45 Million CNY | -660.36% |
| 2019 Q4 | -180.7 Million CNY | 47.08% |
| 2019 Q2 | 60.93 Million CNY | -9.88% |
| 2018 Q1 | 60.09 Million CNY | 33.02% |
| 2018 FY | 229.66 Million CNY | 31.0% |
| 2018 Q3 | 45.04 Million CNY | -32.81% |
| 2018 Q4 | 57.48 Million CNY | 27.61% |
| 2018 Q2 | 67.04 Million CNY | 11.56% |
| 2017 Q2 | 64.36 Million CNY | 101.46% |
| 2017 Q1 | 31.95 Million CNY | -39.07% |
| 2017 Q3 | 33.82 Million CNY | -47.45% |
| 2017 FY | 175.31 Million CNY | 6.24% |
| 2017 Q4 | 45.17 Million CNY | 33.56% |
| 2016 Q1 | 41.8 Million CNY | 41.39% |
| 2016 Q2 | 39.02 Million CNY | -6.66% |
| 2016 FY | 165.02 Million CNY | 111.36% |
| 2016 Q3 | 31.76 Million CNY | -18.6% |
| 2016 Q4 | 52.43 Million CNY | 65.08% |
| 2015 FY | 78.08 Million CNY | 97.83% |
| 2015 Q4 | 29.56 Million CNY | 72.62% |
| 2015 Q2 | 17.86 Million CNY | 32.24% |
| 2015 Q1 | 13.51 Million CNY | 39.2% |
| 2015 Q3 | 17.12 Million CNY | -4.14% |
| 2014 Q2 | 11.01 Million CNY | 6.14% |
| 2014 Q3 | 8.36 Million CNY | -24.03% |
| 2014 Q4 | 9.7 Million CNY | 16.0% |
| 2014 FY | 39.46 Million CNY | 10.87% |
| 2014 Q1 | 10.37 Million CNY | 229.09% |
| 2013 Q4 | 3.15 Million CNY | -45.89% |
| 2013 Q2 | 10.4 Million CNY | -35.78% |
| 2013 Q3 | 5.82 Million CNY | -44.0% |
| 2013 FY | 35.59 Million CNY | -27.68% |
| 2013 Q1 | 16.2 Million CNY | 167.14% |
| 2012 Q3 | 6.52 Million CNY | -41.96% |
| 2012 FY | 49.22 Million CNY | 2.33% |
| 2012 Q4 | 6.06 Million CNY | -7.03% |
| 2012 Q1 | 25.39 Million CNY | 298.34% |
| 2012 Q2 | 11.24 Million CNY | -55.73% |
| 2011 Q3 | 5.87 Million CNY | -46.58% |
| 2011 Q1 | 24.86 Million CNY | 188.44% |
| 2011 Q2 | 10.99 Million CNY | -55.79% |
| 2011 Q4 | 6.37 Million CNY | 8.59% |
| 2011 FY | 48.1 Million CNY | 12.81% |
| 2010 Q2 | 10.54 Million CNY | 24.34% |
| 2010 Q4 | 8.61 Million CNY | -42.5% |
| 2010 Q3 | 14.98 Million CNY | 42.12% |
| 2010 Q1 | 8.48 Million CNY | 93.15% |
| 2010 FY | 42.63 Million CNY | 30.0% |
| 2009 Q1 | -12.3 Million CNY | -412.53% |
| 2009 Q4 | 4.39 Million CNY | -67.67% |
| 2009 Q3 | 13.58 Million CNY | -49.23% |
| 2009 Q2 | 26.76 Million CNY | 317.57% |
| 2009 FY | 32.79 Million CNY | 25.37% |
| 2008 FY | 26.16 Million CNY | 2.23% |
| 2008 Q3 | 7.36 Million CNY | 0.0% |
| 2008 Q4 | 3.93 Million CNY | -46.55% |
| 2007 FY | 25.59 Million CNY | 116.86% |
| 2006 FY | 11.8 Million CNY | 0.0% |